Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs

Journal of the American Veterinary Medical Association

Volumn 218, Issue 7, 2001, Pages 1101-1105

  Smith, Lesley J ^a   Yu, Jeff K A ^a   Bjorling, Dale E ^a   Waller, Kenneth ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; HISTAMINE; HYDROMORPHONE; MORPHINE; OXYMORPHONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; BREATHING RATE; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG SAFETY; HEART RATE; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HYPOTENSION; IMMUNOASSAY; NONHUMAN; OXYGEN SATURATION; PREMEDICATION; PULSE OXIMETER; SCORING SYSTEM; SEDATION; SYSTOLIC BLOOD PRESSURE; VETERINARY MEDICINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0035313407     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.218.1101     Document Type: Article

References (22)

1. Stoelting RK. Opioid agonists and antagonists. In: Stoelting RK, ed. Pharmacology and physiology in anesthetic practice. Philadelphia: JB Lippincott Co, 1991;70-101.
2. Wilson DV. Advantages and guidelines for using opioid agonists for induction of anesthesia. Vet Clin North Am Small Anim Pract 1992;22:269-272.
3. Grossman M, Abiose A, Tagphao O, et al. Morphine-induced venodilation in humans. Clin Pharmacol Ther 1996;60:554-560.
4. Robinson EP, Faggella AM, Henry DP, et al. Comparison of histamine release induced by morphine and oxymorphone administration in dogs. Am J Vet Res 1988;49:1699-1701.
5. Bednarski RM. Anesthesia and immobilization of specific species: dogs and cats. In: Thurmon JC, Tranquilli WJ, Benson GJ, eds. Veterinary anesthesia. Philadelphia: The Williams & Wilkins Co, 1996;591-599.
6. Dyson DH, Atilola M. A clinical comparison of oxymorphone-acepromazine and butorphanol-acepromazine sedation in dogs. Vet Surg 1992;21:418-421.
7. Jacobson JD, McGrath CJ, Smith EP. Cardiorespiratory effects of four opioid-tranquilizer combinations in dogs. Vet Surg 1994;23:299-306.
8. Sackman JE. Pain. Part II. Control of pain in animals. Compend Contin Educ Pract Vet 1991;13:181-192.
9. Vesal N, Cribb PH, Frketic M. Postoperative analgesic and cardiopulmonary effects in dogs of oxymorphone administered epidurally and intramuscularly, and medetomidine administered epidurally: a comparative clinical study. Vet Surg 1996;25:361-369.
10. Pettifer G, Dyson D. Hydromorphone: a cost-effective alternative to the use of oxymorphone. Can Vet J 2000;41:135-137.
11. Inturrisi CE, Foley KM. Analgesics: neurochemical, behavioral, and clinical perspectives. New York: Raven Press, 1984;257.
12. Popovic NA, Mullane JF, Yhap EO. Effects of acetylpromazine maleate on certain cardiorespiratory responses in dogs. Am J Vet Res 1972;33:1819-1824.
13. Cornick JL, Hartsfield SM. Cardiopulmonary and behavioral effects of combinations of acepromazine/butorphanol and acepromazine/oxymorphone in dogs. J Am Vet Med Assoc 1992;200:1952-1956.
14. Copland VS, Haskins SC, Patz JD. Oxymorphone: cardiovascular, pulmonary, and behavioral effects in dogs. Am J Vet Res 1987;48:1626-1630.
15. Copland VS, Haskins SC, Patz J. Naloxone reversal of oxymorphone effects in dogs. Am J Vet Res 1989;50:1854-1858.
16. Copland VS, Haskins SC, Patz JD. Cardiovascular and pulmonary effects of atropine reversal of oxymorphone-induced bradycardia in dogs. Vet Surg 1992;21:414-417.
17. Stepien RL, Bonagura JD, Bednarski RM, et al. Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogs (published erratum appears in Am J Vet Res 1995;56:402). Am J Vet Res 1995;56:78-84.
18. Ludders JW, Reitan JA, Martucci R, et al. Blood pressure response to phenylephrine infusion in halothane-anesthetized dogs given acetylpromazine maleate. Am J Vet Res 1983;44:996-999.
19. Ennis M, Schneider C, Nehring E, et al. Histamine release induced by opioid analgesics: a comparative study using porcine mast cells. Agents Actions 1991;33:20-22.
20. Doenicke A, Moss J, Lorenz W, et al. Intravenous morphine and nalbuphine increase plasma histamine and catecholamine release without accompanying hemodynamic changes. Clin Pharmacol Ther 1995;58:81-89.
21. Gyongyosi M, Kaszaki J, Wolfard A, et al. Acute myocardial infarction enhances the portal venous histamine level in dogs. Inflamm Res 1997;46:253-259.
22. Zia PK, Namei N, Patel A, et al. Fully automated enzyme immunoassay system for determination of activator-specific histamine release from basophils in whole blood. Clin Chem 1998;44: 2063-2065.